About Juno Bio
Juno Bio is a company based in London (United Kingdom) founded in 2018 by Hana Janebdar. The company has 5 employees as of June 30, 2021. Juno Bio operates in a competitive market with competitors including Atlas Biomed, OMED Health, Nylos and Biomesight, among others.
- Headquarter London, United Kingdom
- Employees 5 as on 30 Jun, 2021
- Founders Hana Janebdar
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Juno Bio Limited
- Date of Incorporation 11 Jun, 2018
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Illumina
& 2 more
-
Employee Count
5
as on Jun 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Juno Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Juno Bio
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Seed - Juno Bio | Valuation |
investors |
|
| Apr, 2019 | Amount | Seed - Juno Bio | Valuation |
investors |
Investors in Juno Bio
Juno Bio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, Pink Salt Ventures and AI Seed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage investments are provided to female-led technology companies.
|
Founded Year | Domain | Location | |
|
AI Seed is recognized as a leading AI venture capital fund in Europe.
|
Founded Year | Domain | Location | |
|
Developer of technologies for analysis of genetic variation and function
|
Founded Year | Domain | Location |
Investments & Acquisitions by Juno Bio
Financial Statements - Juno Bio
Juno Bio Comparisons
Competitors of Juno Bio
Juno Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atlas Biomed, OMED Health, Nylos and Biomesight, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetic tests are offered via DNA and gut microbiome analysis.
|
|
| domain | founded_year | HQ Location |
Offers at-home breath testing and treatment for digestive health conditions.
|
|
| domain | founded_year | HQ Location |
Offers online gut microbiome testing for personalized diet planning.
|
|
| domain | founded_year | HQ Location |
Offers gut microbiome analysis, testing kits, and personalized supplement recommendations.
|
Latest news on Juno Bio
Frequently Asked Questions about Juno Bio
Juno Bio was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Juno Bio is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Hana Janebdar is the current CEO of Juno Bio. They have also founded this company.
As of Jun 30, 2021, the latest employee count at Juno Bio is 5.
Juno Bio was established in 2018 and is based in London, United Kingdom. Operations are centered in the biotechnology sector, with a focus on microbiome research. Services encompassing microbiome analysis and related scientific investigations are offered to support client needs. The company is led by Co-Founder and CEO Hana Janebdar, emphasizing factual advancements in microbial studies within a global context.
Juno Bio's top competitors include Atlas Biomed, OMED Health and Nylos.
Juno Bio has 3 investors. Key investors include Illumina, Pink Salt Ventures, and AI Seed.